- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 210
Binx links to $104m in series E round
Johnson & Johnson’s investment arm has returned to back the molecular diagnostic technology developer, which also counts Novartis, Consort Medical and Wondfo Biotech as investors.
Jun 1, 2021Daily deal net: May 31, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
May 31, 2021Daily deal net: May 28, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
May 28, 2021QuintoAndar hikes to $300m series E
SoftBank Innovation Fund has chipped in for a round that valued the rental listings marketplace at $4bn, increasing its overall funding to $635m.
May 28, 2021SoftBank lands on Perch for $775m round
SoftBank Vision Fund 2 led the e-commerce holding company's latest round, reportedly the largest series A ever closed by a US-based company.
May 27, 2021Ivi activates $250m series D
VTB has led the Prof-Media-backed video streaming service’s series D round, which reportedly brought its overall financing to $438m.
May 27, 2021Invaio Sciences infused with series C funding
Alexandria Venture Investments has participated in an $88.9m round which has pushed the biotech developer's total funding past $142m.
May 27, 2021Novo escorts Esco to $200m series A
The pharmaceutical firm co-led a series A equity and crossover financing round for the life sciences tool provider that will fund Chinese expansion.
May 27, 2021NiKang nicks $200m in series C round
Lilly Asia Ventures has returned to back the immuno-oncology therapy developer’s latest round, eight months after participating in the company’s series B.
May 27, 2021Akili scores $160m in series D funding
Shionogi has joined subsidiaries of Merck Group and Amgen in the equity portion of a series D round for the digital therapeutics developer.
May 27, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


